Landong, Reynaldo Jr. L.

HRN: 29-14-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
COTRIMOXAZOLE 960MG (TAB)
06/21/2026
07/11/2026
PO
160/800mg
TID
Pneumonia In Immunocompromised Host
Pending Pharmacy Acceptance 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: